INS and polycystic ovary syndrome: Animal models of prenatal testosterone treatment support clinical studies of PCOS women by inducing permanent PCOS-like phenotypes characterized by LH hypersecretion due to reduced steroid negative feedback, hyperandrogenism, ovulatory dysfunction, and impaired glucose–insulin homeostasis.